The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET PULSE-Acura, Daktronics, DSW, First Solar, PetroLogistics

Wed, 28th May 2014 13:52

(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s)U.S. stocks were little changed on Wednesday, with technicals infocus and scant key items on the U.S. economic calendar,following yet another record close on the benchmark S&P 500index. The Dow Jones industrial average was down 0.11percent at 16,657.33, the S&P 500 was up 0.02 percent at1,912.33 and the Nasdaq Composite was up 0.46 points or0.01 percent to 4,237.53.

** FIRST SOLAR INC, $63.25, +3.25 pct

Brokerage Stifel Nicolaus resumed its rating on the solarmodule maker's stock with a "buy' rating and a target price of$75. Analysts believe the company is well placed "to takeadvantage of global solar PV growth tailwinds" with growth inannual installation to about 60 GW in 2016.

** OILTANKING PARTNERS LP, Tuesday close $87.62,+2.24 pct premarket

The pipeline and storage company announced on Wednesdayplans for a two-for-one unit split. "The unit split will makethe partnership's units more accessible to a broader base ofpotential investors and enhance liquidity for all unitholders,"Chief Executive Ken Owen said.

** SANDISK CORP, Tuesday close $95.5, +0.98 pctpremarket

UBS Investment Research on Tuesday raised its price targetto $110 from $90 on the memory chipmaker's stock, as itanticipates the shift to 3D NAND from 2D NAND to boost averageselling price of memory chips.

** DAKTRONICS INC, Tuesday close $14.47, -10.16 pctpremarket

The supplier of electronic displays and scoreboards reportedlower-than-expected results for the fourth quarter, hurt by afall in sales of its schools & theaters and transportationbusinesses.

** PETROLOGISTICS LP, $14.19, +9.74 pct

A Koch Industries Inc unit will takePetroLogistics LP private in a deal worth $2.1 billion,including debt, gaining control of a plant that can convertcheap U.S. shale gas into propylene, a key petrochemical used tomake plastics. PetroLogistics shares were the top percentagegainers on the New York Stock Exchange.

** DSW INC, $24, -26.20 pct

The shoe retailer reported first-quarter results that missedanalysts' estimates, hurt by unseasonal weather and anaggressively promotional retail environment. The company alsoforecast fiscal 2014 adjusted earnings below the average analystestimate. DSW shares were the top percentage loser on the NewYork Stock Exchange.

** TWITTER INC, $31.47, +3.15 pct

Nomura Securities raised its rating on the microbloggingwebsite's shares to "buy" from "neutral", saying advertising onTwitter is steadily becoming a bigger part of ad budgets and itsrevenue from outside the United States is expected to grow.

** ACURA PHARMACEUTICALS INC, $1.03, -18.25 pct

The biotechnology company on Tuesday said the U.S. healthregulator advised Acura that mid-stage study data of its experimental drug to deter the abuse of ahydrocodone/acetaminophen painkiller, are insufficient tosupport an intranasal abuse deterrence claim.

The hydrocodone/acetaminophen combination painkiller, widelyreferred to as the generic vicodin, is sold under a variety ofnames.

** CHINA SUNERGY CO LTD, $3.43, -9.50 pct

The solar company reported a smaller loss in the firstquarter, helped by increase in shipments to higher-marginmarkets like Japan and France. Net income attributable toshareholders narrowed to $14.7 million, or 99 cents per Americandepository share (ADS) in the quarter ended March 31, from $22.9million, or $1.71 per ADS, a year earlier.

** WET SEAL INC, $0.9, -10.89 pct

Women's apparel retailer reported a bigger-than-expectedquarterly loss, hurt by a double-digit fall in comparable-storesales.

** JDS UNIPHASE CORP, $11.208, +2.64 pct

The maker of fiber optic components used in networkcommunication equipment said on Tuesday it will buy back up to$100 million of its common stock through open market or privatetransactions.

The company, which had $926.2 million in cash on March 29,will repurchase the shares by June 27, 2015.

** MAGNUM HUNTER RESOURCES CORP, $7.63, +4.09 pct

The oil and gas producer said it would sell 21.4 millionshares of the company's common stock at $7 each in a privateoffering. The offer represents a 4.5 percent discount to thestock's Tuesday close of $7.33.

** BIOCRYST PHARMACEUTICALS INC, $9.69, -3.00 pct

The company said it plans to sell some shares and estimatedthat its full-year operating expenses would be at the higher endof the $48 million-$59 million it had earlier forecast.Accelerated development of its oral hereditary disorder drugwould push up costs.

BioCryst on Tuesday said the preventive hereditaryangioedema treatment was found superior to a placebo in amid-stage trial.

** HEALTH CARE REIT INC, $62.28, -3.34 pct

The real estate investment trust was offering 12 millioncommon shares and would use part of the net proceeds to investin healthcare and housing properties along with the repayment ofadvances under its primary unsecured credit facility. Thecompany said it expected to acquire around $414 million ofsenior housing and medical housing properties in second quarter.

** 3D SYSTEMS CORP, $51.8, -8.55 pct

The 3D printer maker announced an offering of 6 millionshares on Tuesday. It plans to use the proceeds foracquisitions.

Pacific Crest cut its price target on the stock to $59 from$65 on Wednesday, saying that plans for making a largeacquisition will do little to quell concerns that the company isgrowing primarily through acquisitions.

** FORMFACTOR INC, $6.7, +9.48 pct

The semiconductor wafer probe maker raised itssecond-quarter revenue forecast as it expects higher sales ofits memory chips. The company raised its revenue forecast tobetween $65 million and $69 million from $62 to $66 million.

Brokerage B. Riley & Co raised its rating on the stock to"buy", while Needham & Co raised its price target to $9 from $8.

** QIHOO 360 TECHNOLOGY CO LTD, $95.07, +5.66 pct

The China-based antivirus software maker and search engineprovider on Tuesday reported better-than-expected first-quarterprofit and revenue, helped by higher subscription for thecopany's mobile security product.

** WORKDAY INC, $81.75, -0.46 pct

The software vendor raised its full-year revenue forecastafter reporting better-than-expected quarterly revenue as morecompanies, especially in the financial sector, opted for itsweb-based human resources software.

** TOLL BROTHERS INC, $36.84, +3.37 pct

** D.R. HORTON INC, $23.48, +1.51 pct

** PULTEGROUP INC, $19.99, +0.96 pct

** LENNAR CORP, $40.96, +1.21 pct

** KB HOME, $16.8, +1.33 pct

The largest U.S. luxury homebuilder said quarterly profitmore than doubled as it sold more homes at higher prices.

Shares of peers D.R. Horton, Pultegroup, Lennar and KB Homewere also up on the news.

** ALLERGAN INC, $157.57, -4.51 pct

** VALEANT PHARMACEUTICALS INTERNATIONAL INC,$124.44, -4.24 pct

Canadian drugmaker Valeant Pharmaceuticals raisedthe cash component of its unsolicited offer for Botox-makerAllergan, valuing the U.S. firm at $49.44 billion and ratchetingup pressure on the target company. Valeant's sweetened offeralso included a contingent value right that could be worth anadditional $7.6 billion.

Also, Nestle SA said it was boosting its emergingskincare business by buying the rights to several dermatologyproducts from the Canadian drugmaker for $1.4 billion in cash.

** SYNAPTICS INC, $63.3, +4.68 pct

Japanese semiconductor manufacturer Renesas Electronics Corp plans to sell its majority stake in a maker of displaychips for Apple Inc's iPhone to the smartphone chipsupplier, according to sources familiar with the matter.

** GLAXOSMITHKLINE PLC, $54.33, -1.15 pct

Britain's fraud office has launched a formal criminalinvestigation into the drugmaker, posing a new challengeto the company, which already faces claims of bribery in Chinaand four other countries.

** TATA MOTORS LTD, $38.91, -2.04 pct

India's largest automaker by revenue, said its domesticoperations would likely not post a profit or would have"inadequate" profit for the fiscal year that ended in March,hurt by sluggish demand.

** CLIFFS NATURAL RESOURCES INC, $15.93, -2.69 pct

The miner fighting an activist investor who wants to splitit up and replace its CEO, said on Tuesday it will cut 2014capital spending by $100 million - or 25 percent - as it dealswith weak seaborne iron ore and metallurgical coal prices.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.